Sign in Subscribe
Genetic research

Breakthrough in Gastric Cancer Treatment: Nanosystem Shows Promise

Strategic Insights

— 1 min read

Researchers from Zhumadian Central Hospital have developed a novel photothermal nanosystem that demonstrates superior cytocompatibility, stimuli-responsive drug release, improved tumor-specific targeting, and efficient cell death of gastric cancer cells. By encapsulating carbon quantum dots (CDs) and the gastric cancer drug camptothecin (CT) in liposomes, the researchers created a multifunctional photothermal nanosystem. The nanosystem was triggered by an NIR laser, resulting in a photothermal conversion efficacy of up to 46.97%. The findings suggest that this approach could enhance the therapeutic efficiency of gastric cancer therapy and offer a potential approach for designing and developing synergistic chemo-photothermal combination therapies.

Key Takeaways:

  • The researchers developed a novel photothermal nanosystem that demonstrates superior cytocompatibility and stimuli-responsive drug release.
  • The nanosystem was triggered by an NIR laser, resulting in a photothermal conversion efficacy of up to 46.97%.
  • The multifunctional photothermal nanosystem was effective in targeting and killing gastric cancer cells through multimodal synergic treatment.
  • The study used camptothecin (CT) as the gastric cancer drug and discovered a targeted and controlled release of the drug using the nanosystem.
  • The nanosystem has the potential to enhance the therapeutic efficiency of gastric cancer therapy.
  • The study demonstrated improved tumor-specific targeting and stimuli-responsive drug release using the nanosystem.
  • The researchers used a combination of chemotherapy and photothermal therapy to achieve synergistic effects in cancer treatment.
  • The study highlights the potential of using nanotechnology in designing and developing cancer therapies.

Statistics:

  • The photothermal conversion efficacy of the nanosystem was up to 46.97%.
  • The nanosystem demonstrated stimuli-responsive drug release.
  • The nanosystem was effective in destroying 80% of NCI-N87 gastric cancer cells through multimodal synergic treatment.
  • The study used camptothecin (CT) as the gastric cancer drug.
  • The nanosystem demonstrated superior cytocompatibility.

Sources:

  • Journal of Materials Science, 2025;36(1):82.
  • Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. (www.springer.com)
  • Dongdong Gao, Dept. of Oncology, Zhumadian Central Hospital, Zhumadian, People's Republic of China.

Read more